Needham & Company Starts Invacare (IVC) at Buy; 'More Aggressive Restructuring Could Unlock Value'
Tweet Send to a Friend
Needham & Company analyst Mike Matson initiates coverage on Invacare (NYSE: IVC) with a Buy rating and a price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
